Testing effectiveness (Phase 2)Study completedNCT02280694What this trial is testingLow Dose Metronomic Poly-chemotherapy for Metastatic CRCWho this might be right forColorectal Cancer HaEmek Medical Center, Israel 45
Testing effectiveness (Phase 2)Study completedNCT03800602What this trial is testingNivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal CancerWho this might be right forColorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaRefractory Colorectal Carcinoma+5 more Emory University 29
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Testing effectiveness (Phase 2)UnknownNCT00303745What this trial is testingIrinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryWho this might be right forColorectal Cancer Federation Francophone de Cancerologie Digestive 78
Testing effectiveness (Phase 2)UnknownNCT03567629What this trial is testingEvaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal CancerWho this might be right formCRC Peking University 130
Testing effectiveness (Phase 2)Ended earlyNCT05169437What this trial is testingNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsWho this might be right forSolid TumorBreast TumorColon Tumor, Malignant+9 more Tempus AI 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570914What this trial is testingHepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesWho this might be right forColorectal Cancer Liver Metastases (CRLM)Colorectal CancerLiver Metastasis Tianjin Medical University Cancer Institute and Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00030563What this trial is testingSurgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the LiverWho this might be right forColorectal CancerMetastatic Cancer University of Washington
Not applicableStudy completedNCT01834014What this trial is testingExploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesWho this might be right forLiver MetastasisColorectal Cancer EPS Corporation 110
Testing effectiveness (Phase 2)UnknownNCT04970914What this trial is testingAnlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003Who this might be right forColorectal Cancer Peking Union Medical College Hospital 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04230187What this trial is testingBevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer Yanhong Deng 528
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Ended earlyNCT06194877What this trial is testingInvestigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal CancersWho this might be right forColorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers MapKure, LLC 13
Testing effectiveness (Phase 2)Study completedNCT03439462What this trial is testingNab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Metastatic Aadi Bioscience, Inc. 60
Early research (Phase 1)UnknownNCT05213195What this trial is testingNKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal CancerWho this might be right forRefractory Metastatic Colorectal Cancer Zhejiang University 38
Testing effectiveness (Phase 2)Ended earlyNCT01545141What this trial is testingChemokine-Modulatory Regimen for Recurrent Resectable Colorectal CancerWho this might be right forColorectal CancerColorectal CarcinomaColorectal Tumors+1 more Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT02860546What this trial is testingA Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRCWho this might be right forRefractory Metastatic Colorectal Cancer Taiho Oncology, Inc. 18
Not applicableStudy completedNCT00897754What this trial is testingGene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving BevacizumabWho this might be right forColorectal Cancer ECOG-ACRIN Cancer Research Group 200
Not applicableUnknownNCT06091683What this trial is testingAdjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC)Who this might be right forPeritoneal Metastases From Colorectal Cancer Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 10
Large-scale testing (Phase 3)Study completedNCT00063141What this trial is testingStudy of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerWho this might be right forColorectal Cancer Eli Lilly and Company 1,302